Source link : https://newshealth.biz/health-news/nirsevimab-cuts-rsv-hospitalizations-in-spanish-study/
TOPLINE: The introduction of universal passive immunisation with nirsevimab, a long-acting monoclonal antibody, led to significant reductions in hospitalizations and paediatric intensive care admissions for respiratory syncytial virus–associated lower respiratory tract infections (RSV-LRTIs), particularly benefiting infants younger than 6 months. METHODOLOGY: Researchers carried out a prospective observational study at a tertiary hospital in Spain to […]
The post Nirsevimab Cuts RSV Hospitalizations in Spanish Study first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-26 12:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8